HCC patients with positive BAP1 expression tended to have multiple tumors than patients with negative BAP1, despite that, there were no significant differences between these two groups regarding gender, age, and other clinicopathologic characteristics. This evidence concerns the gene BAP1 and hepatocellular carcinoma.